期刊文献+

左旋氨氯地平治疗心血管相关疾病的研究进展 被引量:44

Progress of l-amiodipine in cardiovascular diseases
在线阅读 下载PDF
导出
摘要 左旋氨氯地平是新一代的钙通道阻滞药,是氨氯地平的更新换代产品,临床上主要用于治疗高血压病、心绞痛,并且用于纠正心肌肥厚、心力衰竭等病理状态。本文综述了左旋氨氯地平在治疗高血压病及其他心血管相关疾病方面的最新研究进展,并展望其应用前景。 L-amlodipine is a novel calcium channel blocker (CCB) as an alternative to amlodipine for the treatment of hypertension and angina peetoris. L-amlodipine could ameliorate myocardial hypertrophy and prevent heart failure. The new progress of l-amlodipine in the treatment of cardiovascular disease, such as hypertension, angina peetoris and heart failure, was reviewed and the prospect was also discussed in this paper.
作者 黄仲义
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2008年第3期236-238,共3页 Chinese Journal of New Drugs and Clinical Remedies
关键词 抗高血压药 钙通道阻滞药 高血压 心绞痛 心血管疾病 左旋氨氯地平 antihypertensive agents calcium channel blockers hypertension angina pectoris cardiovascular disease l-amlodipine
  • 相关文献

参考文献18

二级参考文献45

  • 1刘遂心,孙明,李彤.左旋氨氯地平对缺氧心肌细胞乳酸脱氢酶和肌钙蛋白的影响[J].中国动脉硬化杂志,2005,13(1):34-36. 被引量:3
  • 2[1]Yamaha S, Sugimoto N, Uchida S, etal. Pharmacokinetics of amlodipine and its occupancy of calcium antagonist receptors[J]. J Cardiovasc Pharmacol, 1994,23(3) :466 - 472.
  • 3[2]Nordlander M, Abrahamasson T, Akerblom B, et al. Vascular versus myocardial selectivity of dihydropyridine calcium antagonists as studied in vivo and in vitro[J]. Pharmacol Toxicol, 1995,76(1) :56- 62.
  • 4[3]Elkayam U, Amin J, Mehra A, et al. A prospective, randomized,double- blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure[J].Circulation, 1990,82(6): 1954 - 1961.
  • 5[4]Goldstein RE, Boccuzzi SJ, Cruess D, et al. Diltiasem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction[J]. Circulation, 1991,83(1) :52 - 60.
  • 6[5]Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction[J]. N Engl J Med,1988,319(7):358- 392.
  • 7[6]Packer M, Nicod P, Bijoy R, et al. Randomized, multicenter, double- blind, placebo - controlled evaluation of amlodipine in patients with mild-moderate heart failure[J]. J Am Coll Cardiol, 1991,17(2):274A.
  • 8[7]Packer M, Christopher M, O' Connor CM, et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure[ J]. N Engl J Med, 1996,335(15): 1107 - 1114.
  • 9[8]Kloner RA, Sowers JR, DiBona GF, et al. Effect of amlodipine on left ventricular mass in the amlodipine cardiovascular community trial[J].J Cardiovase Pharm. acol, 1995,26:471-476.
  • 10[9]Lombardo M, Alli C, Broccolino M,et al. Long- term effects of angiotensin- converting enzyme inhibitors and calcium antagonists on the right and left ventricles in essential hypertension [ J ]. Am Heart J,1997,134(3) :557 - 564.

共引文献211

同被引文献252

引证文献44

二级引证文献192

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部